Marta Jornet

Marta Jornet serves as the Prescription Medicine Business Unit Head at Angelini Pharma España since June 2017, leading the transformation of a local business unit into a global entity focused on brain health, achieving significant recognition and success in psychiatry. Noteworthy achievements include being recognized by AIMFA for the best launch in Spain with the ONTORZY treatment for uncontrolled epilepsy. Additionally, Marta is a collaborative professor at EADA Business School for the Master in Pharmaceutical Marketing. Marta's previous experience spans various roles at Angelini Farmacéutica from 2000 to 2017, where significant contributions included establishing a hospital line to enhance patient care and expanding the Ophthalmology department's portfolio. Educational qualifications include a Licenciada en Farmacia from U.B. Universidad de Barcelona, a Master's in Pharmaceutical Marketing from EADA Business School, and a PDD from IESE Business School.